FDA Approves Bausch + Lomb TRULIGN Astigmatism Correction Lens

Bausch + Lomb, global ophthalmic-focused company, has earned FDA approval for its TRULIGN Toric intraocular lens.

Advertisement

The TRULIGN is designed to correct astigmatism and to improve vision across a natural range of focus.

More Articles on Ophthalmology:
Dr. David Vollman Heads VA Cataract Surgery Outcomes Data Collection
Dr. Eva Liang Opens Center for Sight in Las Vegas
Dr. Thomas Findlan Plans New Freestanding Pittsburgh Eye Location

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.